Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 and Aspirin as Adjunctive Therapy for Chronic Periodontitis
NCT01113528Phase 2
Key facts
- Status
- Completed
- Start
- Nov 2009
- Primary completion
- Dec 2009
- Countries
- 1
- Sponsor
- October 6 University
- Modality
- Orthosteric Ligands
- Conditions
- chronic periodontitis
01
Overview
Phase 2, randomised, double-blind trial of omega-3 fatty acid and aspirin in chronic periodontitis (2 arms), sponsored by October 6 University. Primary endpoint: Cytokine levels at 6 months. Started Nov 2009; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Regenerative therapy
Bone graft + Omega-3 + Aspirin
Sugar pill
Bone graft + Placebo
03
Who it enrols
Patients with moderate to severe chronic periodontitis and at least one grade II furcation defect, free from systemic diseases and not receiving medications affecting periodontal status.
04
Endpoints
Primary
Cytokine levels
Secondary
Gingival inflammation
Healing after regenerative therapy
Beyond the preview
Go deeper on NCT01113528.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01113528.